These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1372861)

  • 61. Immunoglobulin use in immune deficiency and autoimmune disease states.
    Perez EE
    Am J Manag Care; 2019 Jun; 25(6 Suppl):S92-S97. PubMed ID: 31318514
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune globulin IV therapy: optimizing care of patients in the oncology setting.
    Shelton BK; Griffin JM; Goldman FD
    Oncol Nurs Forum; 2006 Sep; 33(5):911-21. PubMed ID: 16955119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Current applications of immunoglobulin therapy].
    Helmke K
    Fortschr Med; 1994 May; 112(15):213-7. PubMed ID: 8050765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992.
    Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549
    [No Abstract]   [Full Text] [Related]  

  • 65. Antibody-directed therapy: past, present, and future.
    Gelfand EW
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S111-6. PubMed ID: 11586277
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Intravenous immunoglobulins (IgIV) in the treatment of autoimmune diseases and systemic inflammatory diseases].
    Kazatchkine M
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):209-10. PubMed ID: 8337128
    [No Abstract]   [Full Text] [Related]  

  • 67. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.
    Wong PH; White KM
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
    Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
    Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of IGIV in the treatment of immune-mediated dermatologic disorders.
    Gelfand EW
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):92-6. PubMed ID: 14870993
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 7th International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous immunoglobulin in oncology nursing practice.
    Timmerman PR
    Oncol Nurs Forum; 1993; 20(1):69-75. PubMed ID: 8421651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease.
    Patel NC
    Pediatr Allergy Immunol; 2018 Sep; 29(6):583-588. PubMed ID: 29744952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 78. The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.
    Stein MR
    Postgrad Med; 2010 Sep; 122(5):176-84. PubMed ID: 20861601
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prevention of infections in primary and secondary antibody deficiency].
    Mikołuć B; Pietrucha B; Motkowski R; Wolska-Kuśnierz B; Heropolitańska-Pliszka E; Bernatowska E
    Przegl Epidemiol; 2009; 63(1):55-60. PubMed ID: 19522227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Secondary immunodeficiencies].
    Giraldo Castellano P
    Sangre (Barc); 1999 Apr; 44(2):155-61. PubMed ID: 10382325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.